A Pilot, Phase I/II Study of the Amino Acid Leucine in the Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia (LeucineDBA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by North Shore Long Island Jewish Health System
Sponsor:
Information provided by (Responsible Party):
Adrianna Vlachos, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT01362595
First received: May 20, 2011
Last updated: May 19, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)